Ayça Altay Benetti achieved a significant milestone by completing her PhD in pharmacokinetics and biopharmaceutics in 2021 from the University of Parma, Italy. She founded PronioBioTech, a startup in transdermal drug delivery for arthritis treatment, thanks to the NUS GRIP 10 innovation program. Through her strategic leadership and vision, the company is advancing innovation in the field. She has deep understanding of the pharmaceutical industry, drug delivery technologies, and regulatory requirements has propelled her company’s success. She has presented papers at over ten national and international conferences and has 17 publications in reputable journals. Currently, Ayça is a research fellow at the National University of Singapore, continuing her pioneering work. Her journey, from an ambitious student in Parma to an influential entrepreneur and researcher in Singapore, exemplifies her tenacity, expertise, and visionary approach. Ayça Altay Benetti continues to inspire and lead advancements in pharmacokinetics and biopharmaceutics.